BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) declared a monthly dividend on Friday, June 5th. Stockholders of record on Friday, August 14th will be given a dividend of 0.2621 per share on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 7.0%. The ex-dividend date of this dividend is Friday, August 14th.
BlackRock Health Sciences Trust Price Performance
Shares of BME opened at $44.66 on Wednesday. BlackRock Health Sciences Trust has a 52 week low of $35.28 and a 52 week high of $44.99. The business’s 50 day moving average price is $42.21 and its 200-day moving average price is $40.96.
Institutional Trading of BlackRock Health Sciences Trust
Several institutional investors have recently bought and sold shares of BME. Northwestern Mutual Wealth Management Co. boosted its stake in BlackRock Health Sciences Trust by 285,436.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after purchasing an additional 4,044,638 shares during the last quarter. Truist Financial Corp increased its holdings in BlackRock Health Sciences Trust by 23.7% in the 4th quarter. Truist Financial Corp now owns 6,811 shares of the company’s stock worth $280,000 after buying an additional 1,306 shares in the last quarter. AlphaStar Capital Management LLC raised its position in BlackRock Health Sciences Trust by 2.2% in the 4th quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after buying an additional 258 shares during the last quarter. Calamos Advisors LLC grew its stake in shares of BlackRock Health Sciences Trust by 63.8% in the fourth quarter. Calamos Advisors LLC now owns 26,020 shares of the company’s stock worth $1,070,000 after acquiring an additional 10,135 shares during the period. Finally, Wealthspire Retirement LLC lifted its position in BlackRock Health Sciences Trust by 12.2% during the first quarter. Wealthspire Retirement LLC now owns 51,887 shares of the company’s stock valued at $1,998,000 after purchasing an additional 5,635 shares during the period.
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
- DraftKings’ Predictions Push Could Be the Bet That Matters Most
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
